Reducing 30-Day Readmissions for Sickle Cell Disease (SCD) Patients
  • Author(s): Plaxcedes Mawora; Esiri Aror; Annette Obire Pwajok; Munashe Naphtali Mupa
  • Paper ID: 1713213
  • Page: 2249-2257
  • Published Date: 31-12-2025
  • Published In: Iconic Research And Engineering Journals
  • Publisher: IRE Journals
  • e-ISSN: 2456-8880
  • Volume/Issue: Volume 9 Issue 6 December-2025
Abstract

Sickle Cell Disease (SCD) is a hereditary condition of the blood, which creates enormous healthcare problems, comprise hospitalized readmission rates and hospitalization. The decrease in the 30-day readmission in patients with SCD is a primary task that has caused the rise of costs, aggravated results, and stress on resources. This research aims at comparing the efficacy of discharge planning, pathways of pain management, as well as linkage models in the communities to minimize the readmission rates of SCD patients in an academic health system. The study is designed as a mixed-methods study that entails a retrospective review of the readmission rates with interviews of clinicians and case managers. The quantitative analysis will involve making comparisons of the readmission rates prior to and following the introduction of the structured discharge plans, pain management plans, and post-discharge follow-ups. The challenges of quality in installing these interventions in the minds of healthcare providers are explored in in-depth interviews. There are initial indications that extensive discharge planning, effective pain management and strong linkages to the community greatly minimize the number of readmissions. The interview indicates the significance of effective communication, education of the patients, and follow-up care. The paper is relevant to the body of evidence on integrated and patient-centered care that incorporates both hospital-based and community-based support frameworks to enhance patient outcomes and decrease readmissions of chronic diseases such as SCD. These results can provide practical information that can be used by the healthcare systems to improve the quality of care and decrease the economic cost of readmissions.

Citations

IRE Journals:
Plaxcedes Mawora, Esiri Aror, Annette Obire Pwajok, Munashe Naphtali Mupa "Reducing 30-Day Readmissions for Sickle Cell Disease (SCD) Patients" Iconic Research And Engineering Journals Volume 9 Issue 6 2025 Page 2249-2257

IEEE:
Plaxcedes Mawora, Esiri Aror, Annette Obire Pwajok, Munashe Naphtali Mupa "Reducing 30-Day Readmissions for Sickle Cell Disease (SCD) Patients" Iconic Research And Engineering Journals, 9(6)